Considerations on the Design of Lipid-based mRNA Vaccines Against Cancer-Reference-Cited by-同舟云学术

Considerations on the Design of Lipid-based mRNA Vaccines Against Cancer

Published:2024-01 Issue:2 Volume:436 Page:168385
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Meulewaeter Sofie^ORCID,Zhang Yao,Wadhwa Abishek,Fox Kevin^ORCID,Lentacker Ine^ORCID,Harder Kenneth W.,Cullis Pieter R.,De Smedt Stefaan C.,Cheng Miffy H.Y.,Verbeke Rein^ORCID

Funder

Ghent University

University of British Columbia

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference146 articles.

1. Survival of NSCLC patients treated with Cimavax-EGF as switch maintenance in the real-world scenario;Vega;J. Cancer,2023

2. Cancer vaccines as promising immuno-therapeutics: platforms and current progress;Liu;J. Hematol. Oncol.,2022

3. The dawn of mRNA vaccines: The COVID-19 case;Verbeke;J. Control Release,2021

4. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron;Tarke;Cell,2022

5. COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation;Reinscheid;Nature Commun.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy;Journal of Controlled Release;2024-08

2. mRNA-based vaccines – global approach, challenges, and could be a promising wayout for future pandemics;Pharmaceutical Development and Technology;2024-06-04

3. Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria;Journal of Controlled Release;2024-06